The technology vendor is going outside the company to hire PNC vet Michael Lyons to replace Trump Administration-bound Frank Bisignano, leaving the Pittsburgh-bank without its heir apparent for the ...

Piper Sandler confirmed its positive stance on Atlassian Corporation (NASDAQ:TEAM), maintaining an Overweight stock rating ...

Piper Sandler adjusted its outlook on Commerce Bancshares (NASDAQ:CBSH) stock, raising the price target to $72 from the ...

Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $2.39 which represents a slight increase of $0.02 or 0.84% from the prior close of $2.37. The stock opened at $2.4 and ...

Elon Musk's Tesla could deliver a choppy H1 given tailwinds from Donald Trump's EV policies, uncertainties in deliveries, and gross margin.

Tesla's stock shed early gains Tuesday that came after Trump's move to end the 'EV mandate' Tesla Inc.'s stock shed early gains Tuesday that came on expectations that Chief Executive Elon Musk's close ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Tesla (TSLA) slips as President Trump considers eliminating EV tax credits and subsidies, while Piper Sandler analysts raise ...

Investors are expecting Musk to benefit more broadly from Trump 2.0, possibly through friendlier rules on self-driving or for one of his other initiatives beyond Tesla. Tesla's stock (TSLA) has gained ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Piper Sandler raised the firm’s price target on Tesla (TSLA) to $500 from $315 and keeps an Overweight rating on the shares. The firm says ...